ARNICA, PLUMBUM comp.B ampoules

WALA remedies GmbH

Sale price £96.35 Regular price £130.00

Tax included. Shipping calculated at checkout.

ARNICA/PLUMBUM comp.B ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

Arnica/Plumbum comp. B, liquid dilution for injection. Indications: In accordance with anthroposophical knowledge of man and nature. These include: For adjunctive treatment of circulatory disorders of the brain (cerebral circulatory disorders), for follow-up treatment after a stroke (apoplexy cerebri), degenerative changes in the inner ear with dizziness, tinnitus and hearing loss.

For risks and side effects, read the package insert and ask your doctor or pharmacist.


INSTRUCTIONS FOR USE: INFORMATION FOR THE USER

Arnica/Plumbum comp. B, liquid dilution for injection

Composition:
1 ampoule contains: Arnica montana e planta tota ferm 33c Dil. D28 0.01 g (HAB, Vs. 33c), Betula pendula e cortice, Decoctum Dil. D3 0.01 g (HAB, Vs. 23a), Cerebellum bovis GI Dil. D15 0.01 g (HAB, Vs. 41a), Corpora quadrgemina bovis GI Dil. D15 0.01 g (HAB, Vs. 41a), Epiphysis bovis GI Dil. D15 0.01 g (HAB, Vs. 41a), Labyrinthus bovis GI Dil. D15 0.01 g (HAB, vs. 41a), medulla oblongata bovis GI Dil. D15 0.01 g (HAB, vs. 41a), statoacustic nerve bovis GI Dil. D15 0.01 g (HAB, Vs. 41a), Plumbum mellitum Dil. D28 aquos. 0.02 g (HAB, Vs. 8b). Other ingredients: Sodium chloride, sodium bicarbonate, water for injections.

Indications
: According to anthroposophical understanding of man and nature. These include: For adjunctive treatment of circulatory disorders of the brain (cerebral circulatory disorders), for follow-up treatment after a stroke (cerebrovascular accident), and degenerative changes in the inner ear with dizziness, tinnitus, and hearing loss.

Contraindications:
None known.

Precautions for use and warnings:
There is insufficient documented experience with the use of this medicine in children. It should therefore not be used in children under 12 years of age.

Dosage and method of administration:
Unless otherwise prescribed, inject 1 ml subcutaneously 2 to 3 times weekly.

Duration of use:
The duration of treatment for chronic illnesses requires consultation with a doctor.

Side effects:
None known.

Contents:
10 x 1 ml

Pharmaceutical entrepreneur and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1
73087 Bad Boll/Eckwälden

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalogue
as of: 03/2025

Indications: According to anthroposophical understanding of man and nature. These include: For adjunctive treatment of circulatory disorders of the brain (cerebral circulatory disorders), for follow-up treatment after a stroke (cerebrovascular accident), and for degenerative changes of the inner ear with dizziness, tinnitus, and hearing loss.